- Tiziana Life Sciences has purchased key assets from Shardna SpA, a biobanking and genomics research company located in Sardinia for a total value of €258,000.

Tiziana has also established an Italian subsidiary in Sardinia, LonGevia Genomics Srl, specifically to develop these assets to identify novel drug targets and diagnostic applications, through integration with its global research network.

Story provided by